phosphorus has been researched along with tamoxifen in 9 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaros, D; Hatzikonstantinou, J; Kalef-Ezra, J; Karantanas, A; Klouvas, G; Pavlidis, N; Siamopoulos, KC | 1 |
| Herring, JR; Paul, DC; Williams, DC | 1 |
| Bendel, P; Degani, H; Furman, E; Horowitz, A; Margalit, R | 1 |
| Baluch, S; Coombes, RC; Griffiths, JR; Midwood, CJ; Stubbs, M | 1 |
| Degani, H; Neeman, M | 1 |
| Glaros, D; Hatzikonstantinou, I; Kalef-Ezra, JA; Karantanas, A; Klouvas, G; Pavlidis, N | 1 |
| Brown, IN; Cohen, A; Fleischer, JB; Hershman, DL; Joe, AK; Johnson, MK; McMahon, DJ; Silverberg, SJ | 1 |
| Ajdžanović, V; Filipović, B; Isenović, E; Milošević, V; Popovska-Perčinić, F; Šošić-Jurjević, B; Živanović, J | 1 |
| Bikle, DD; Chen, Y; Deng, X; Ji, S; Jiang, Y; Liao, E; Liao, L; Shrestha, C; Xie, Z; Yuan, Y | 1 |
1 trial(s) available for phosphorus and tamoxifen
| Article | Year |
|---|---|
Prevention of bone loss after withdrawal of tamoxifen.
Topics: Absorptiometry, Photon; Administration, Oral; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Calcium; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Serum Albumin; Substance Withdrawal Syndrome; Tamoxifen; Treatment Outcome | 2008 |
8 other study(ies) available for phosphorus and tamoxifen
| Article | Year |
|---|---|
New evidence that tamoxifen does not induce osteoporosis: a nuclear activation analysis and absorptiometry study.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Breast Neoplasms; Female; Humans; Middle Aged; Neutron Activation Analysis; Osteoporosis; Phosphorus; Spine; Tamoxifen; Time Factors | 1992 |
Effects of antiestrogenic compounds on avian medullary bone formation.
Topics: Alkaline Phosphatase; Animals; Bone Marrow; Calcium; Circadian Rhythm; Coturnix; Estradiol; Estrogen Antagonists; Male; Osteogenesis; Phosphorus; Pyrrolidines; Tamoxifen | 1991 |
In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice.
Topics: Animals; Breast Neoplasms; Female; Humans; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorus; Tamoxifen; Tumor Cells, Cultured | 1991 |
Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS.
Topics: Animals; Female; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylnitrosourea; Nucleotides; Phosphates; Phosphorus; Rats; Rats, Inbred Strains; Tamoxifen | 1991 |
Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.
Topics: Breast Neoplasms; Carbon Isotopes; Cell Line; Clone Cells; Cycloheximide; Dactinomycin; Estradiol; Female; Glucose; Glutamates; Glycolysis; Humans; Lactates; Magnetic Resonance Spectroscopy; Phospholipids; Phosphorus; Tamoxifen; Tumor Cells, Cultured | 1989 |
Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Middle Aged; Phosphorus; Tamoxifen; Time Factors | 1996 |
Tamoxifen stimulates calcitonin-producing thyroid C-cells and prevents trabecular bone loss in a rat model of androgen deficiency.
Topics: Analysis of Variance; Androgens; Animals; Calcitonin; Calcium; Immunoassay; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Orchiectomy; Osteocalcin; Osteoporosis; Phosphorus; Rats; Rats, Wistar; Tamoxifen; Thyroid Gland | 2015 |
p120-Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice.
Topics: 4-Nitroquinoline-1-oxide; Animals; Calcium; Calcium, Dietary; Carcinogenesis; Carcinoma, Squamous Cell; Catenins; Cell Differentiation; Cell Proliferation; Delta Catenin; Epithelium; Gene Deletion; Mice, Inbred C57BL; Mice, Knockout; Mouth Neoplasms; Neoplasm Invasiveness; Parathyroid Hormone; Phosphorus; Quinolones; Tamoxifen | 2017 |